Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer

World Journal of Urology

Volumn 30, Issue 6, 2012, Pages 847-852

  Cha, Eugene K ^a   Tirsar, Lenuta Ancuta ^b,c   Schwentner, Christian ^c   Hennenlotter, Joerg ^c   Christos, Paul J ^a   Stenzl, Arnulf ^c   Mian, Christine ^d   Martini, Thomas ^d   Pycha, Armin ^d   Shariat, Shahrokh F ^a   Schmitz Dräger, Bernd J ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b EuromedClinic Fürth and Urologie24 ^*  (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Carcinoma; Early detection of cancer; Hematuria; Nomograms; Urinary bladder neoplasms

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER TUMOR; COHORT ANALYSIS; EARLY DIAGNOSIS; FEMALE; HEMATURIA; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NOMOGRAM; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; HEMATURIA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84870362563     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-012-0979-x     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60: 277-300.
2. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C et al (2005) Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66: 4-34.
3. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M et al (2007) Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 25: 285-295.
4. Silverman DT, Levin LI, Hoover RN, Hartge P (1989) Occupational risks of bladder cancer in the United States: I. White men. J Natl Cancer Inst 81: 1472-1480.
5. Sutton JM (1990) Evaluation of hematuria in adults. JAMA 263: 2475-2480.
6. Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL et al (2001) Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy-part I: definition, detection, prevalence, and etiology. Urology 57: 599-603.
7. Davis R, Jones SJ, Barocas DA, Castle EP, Lang EK, et al. (2012) diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. American Urological Association Guidelines May 2012.
8. Cohen RA, Brown RS (2003) Clinical practice Microscopic hematuria. N Engl J Med 348: 2330-2338.
9. Nieder AM, Lotan Y, Nuss GR, Langston JP, Vyas S et al (2010) Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey. Urol Oncol 28: 500-503.
10. Johnson EK, Daignault S, Zhang Y, Lee CT (2008) Patterns of hematuria referral to urologists: does a gender disparity exist? Urology 72: 498-502 Discussion 498-502.
11. Summerton N, Mann S, Rigby AS, Ashley J, Palmer S et al (2002) Patients with new onset haematuria: assessing the discriminant value of clinical information in relation to urological malignancies. Br J Gen Pract 52: 284-289.
12. Lotan Y, Capitanio U, Shariat SF, Hutterer GC, Karakiewicz PI (2009) Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. BJU Int 103: 1368-1374.
13. Efron B, Tibshirani R (1993) An introduction to the bootstrap., XviChapman & Hall, New York, p 436.
14. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y et al (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54: 774-781.
15. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387.
16. Lotan Y, Shariat SF, Schmitz-Drager BJ, Sanchez-Carbayo M, Jankevicius F et al (2010) Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. Urol Oncol 28: 441-448.
17. Shariat SF, Lotan Y, Vickers A, Karakiewicz PI, Schmitz-Drager BJ et al (2010) Statistical consideration for clinical biomarker research in bladder cancer. Urol Oncol 28: 389-400.
18. Svatek RS, Lotan Y, Karakiewizc PI, Shariat SF (2008) Screening for bladder cancer using urine-based tumor markers. Minerva Urol Nefrol 60: 247-253.
19. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS (2009) Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare analysis. Cancer 115: 988-996.
20. Wallace DM, Bryan RT, Dunn JA, Begum G, Bathers S (2002) Delay and survival in bladder cancer. BJU Int 89: 868-878.
21. Hollenbeck BK, Dunn RL, Ye Z, Hollingsworth JM, Skolarus TA et al (2010) Delays in diagnosis and bladder cancer mortality. Cancer 116(22): 5235-5242.
22. Shariat SF, Karakiewicz PI, Suardi N, Kattan MW (2008) Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res 14: 4400-4407.
23. Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW (2008) An updated catalog of prostate cancer predictive tools. Cancer 113: 3075-3099.
24. Badalament RA, Hermansen DK, Kimmel M, Gay H, Herr HW et al (1987) The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer 60: 1423-1427.
25. Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S et al (2010) The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 105: 300-308.
26. Karakiewicz PI, Benayoun S, Zippe C, Ludecke G, Boman H et al (2006) Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. BJU Int 97: 997-1001.
27. Buntinx F, Wauters H (1997) The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a meta-analysis. Fam Pract 14: 63-68.
28. Messing EM, Madeb R, Young T, Gilchrist KW, Bram L et al (2006) Long-term outcome of hematuria home screening for bladder cancer in men. Cancer 107: 2173-2179.
29. Ross PL, Gerigk C, Gonen M, Yossepowitch O, Cagiannos I et al (2002) Comparisons of nomograms and urologists' predictions in prostate cancer. Semin Urol Oncol 20: 82-88.
30. Walz J, Gallina A, Perrotte P, Jeldres C, Trinh QD et al (2007) Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int 100: 1254-1258.